Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
273
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices

Alan P. SkarbnikLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Correspondence[email protected]
,
Esprit MaMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Marie-Hélène LafeuilleGroupe d’analyse, Ltée, Montreal, QC, Canada;
,
Jonathan FortierGroupe d’analyse, Ltée, Montreal, QC, Canada;
,
Tatyana FeldmanLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA;
,
Mei Sheng DuhAnalysis Group, Inc, Boston, MA, USA
,
Helgi van de VeldeMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Liviu NiculescuMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Vijayveer BonthapallyMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
&
André GoyLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA;
show all
Pages 1968-1972 | Received 19 Apr 2016, Accepted 11 Dec 2016, Published online: 16 Jan 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgments

This study was funded by Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Janssen Global Services, LLC.

The authors would like to acknowledge the writing assistance of Steve Hill and Helen Johns of FireKite, an Ashfield company, part of UDG Healthcare plc, Maidenhead, UK, during the development of this publication, which was funded by Millennium Pharmaceuticals, Inc., and Janssen Global Services, LLC, and complied with Good Publication Practice 3 ethical guidelines (Battisti et al., Ann Intern Med 2015;163:461–4).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2016.1272688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.